Efficacy and Safety of the Association of Nimodipine and Choline Alphoscerate in the Treatment of Cognitive Impairment in Patients with Cerebral Small Vessel Disease. The CONIVaD Trial

BACKGROUND: No approved treatment is available for patients with vascular cognitive impairment (VCI) due to cerebral small vessel disease (SVD). OBJECTIVE: The CONIVaD (Choline Alphoscerate and Nimodipine in Vascular Dementia) study aimed to investigate the feasibility, efficacy, and safety of a com...

Descripción completa

Detalles Bibliográficos
Autores principales: Salvadori, Emilia, Poggesi, Anna, Donnini, Ida, Rinnoci, Valentina, Chiti, Guido, Squitieri, Martina, Tudisco, Laura, Fierini, Fabio, Melone, Anna, Pescini, Francesca, Pantoni, Leonardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211589/
https://www.ncbi.nlm.nih.gov/pubmed/33855653
http://dx.doi.org/10.1007/s40266-021-00852-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211589/
https://www.ncbi.nlm.nih.gov/pubmed/33855653
http://dx.doi.org/10.1007/s40266-021-00852-8

Ejemplares similares